AU2001276558B2 - Pharmaceutical composition comprising condensed indole compound - Google Patents

Pharmaceutical composition comprising condensed indole compound Download PDF

Info

Publication number
AU2001276558B2
AU2001276558B2 AU2001276558A AU2001276558A AU2001276558B2 AU 2001276558 B2 AU2001276558 B2 AU 2001276558B2 AU 2001276558 A AU2001276558 A AU 2001276558A AU 2001276558 A AU2001276558 A AU 2001276558A AU 2001276558 B2 AU2001276558 B2 AU 2001276558B2
Authority
AU
Australia
Prior art keywords
composition
salt
weight
granules
filler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001276558A
Other languages
English (en)
Other versions
AU2001276558A1 (en
Inventor
Neeta Balkrishan Amin
Philip Christopher Buxton
Bernard Enno Ilson
Gillian Louise Shepherd
Seona Thomson
Dirk Marinus Johannes Van Schie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0019524A external-priority patent/GB0019524D0/en
Priority claimed from GB0118919A external-priority patent/GB0118919D0/en
Priority claimed from GB0119022A external-priority patent/GB0119022D0/en
Priority claimed from PCT/GB2001/003544 external-priority patent/WO2002011766A2/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001276558A1 publication Critical patent/AU2001276558A1/en
Application granted granted Critical
Publication of AU2001276558B2 publication Critical patent/AU2001276558B2/en
Assigned to SMITHKLINE BEECHAM P.L.C. reassignment SMITHKLINE BEECHAM P.L.C. Request for Assignment Assignors: LABORATOIRE GLAXOSMITHKLINE S.A.S., SMITHKLINE BEECHAM P.L.C.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2001276558A 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound Ceased AU2001276558B2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0019524A GB0019524D0 (en) 2000-08-08 2000-08-08 Novel use
GB0019524.8 2000-08-08
GB0118919.0 2001-08-02
GB0118919A GB0118919D0 (en) 2001-08-02 2001-08-02 Novel use
GB0119022A GB0119022D0 (en) 2001-08-03 2001-08-03 Novel use
GB0119022.2 2001-08-03
AUPCT/GB2001/003544 2001-08-07
PCT/GB2001/003544 WO2002011766A2 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
PCT/GB2001/003590 WO2002011733A1 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound

Publications (2)

Publication Number Publication Date
AU2001276558A1 AU2001276558A1 (en) 2002-05-16
AU2001276558B2 true AU2001276558B2 (en) 2005-11-24

Family

ID=27447871

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001276558A Ceased AU2001276558B2 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
AU7655801A Pending AU7655801A (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU7655801A Pending AU7655801A (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound

Country Status (8)

Country Link
EP (1) EP1313481B1 (enExample)
JP (1) JP2004505920A (enExample)
AU (2) AU2001276558B2 (enExample)
CA (1) CA2418921C (enExample)
DE (1) DE60130667T2 (enExample)
DK (1) DK1313481T3 (enExample)
ES (1) ES2294012T3 (enExample)
WO (1) WO2002011733A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003202058B2 (en) * 2002-02-14 2009-05-28 Glaxo Group Limited Pharmaceutical composition comprising N- ((1-N-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2H- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
FR3097215B1 (fr) 2019-06-13 2021-06-11 Sodimas Installation d’ascenseur

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3332830A1 (de) * 1982-09-16 1984-03-22 The Upjohn Co., 49001 Kalamazoo, Mich. Verwendung von benzodiazepinen zur bekaempfung oder bei der behandlung von panikzustaenden
ATE180785T1 (de) * 1992-03-12 1999-06-15 Smithkline Beecham Plc Kondensierte indol-derivate als 5-ht4-rezeptor- antagonisten

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003202058B2 (en) * 2002-02-14 2009-05-28 Glaxo Group Limited Pharmaceutical composition comprising N- ((1-N-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2H- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation

Also Published As

Publication number Publication date
EP1313481B1 (en) 2007-09-26
DE60130667T2 (de) 2008-07-17
DK1313481T3 (da) 2008-01-28
JP2004505920A (ja) 2004-02-26
CA2418921A1 (en) 2002-02-14
EP1313481A1 (en) 2003-05-28
WO2002011733A1 (en) 2002-02-14
CA2418921C (en) 2010-10-26
ES2294012T3 (es) 2008-04-01
AU7655801A (en) 2002-02-18
DE60130667D1 (de) 2007-11-08

Similar Documents

Publication Publication Date Title
TWI405574B (zh) 藥學固體製劑及其製造方法
AU2003202058B2 (en) Pharmaceutical composition comprising N- ((1-N-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2H- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
CN113939289A (zh) 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
HU228040B1 (en) Coated trimebutine maleate tablet
JP2008247915A (ja) 縮合インドール化合物を含む医薬組成物
KR101834559B1 (ko) 에제티미브 및 로수바스타틴을 포함하는 경구용 고형 복합제제
AU2001276558B2 (en) Pharmaceutical composition comprising condensed indole compound
NZ719865A (en) A pharmaceutical dosage form produced from the wet granulation of 3-(2,6-dichloro-3,5- dimethoxy-phenyl)-1-{ 6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl} -1-methylurea
AU2001276558A1 (en) Pharmaceutical composition comprising condensed indole compound
KR100590622B1 (ko) 레보시멘단과 알긴산을 포함하는 안정한 조성물
ZA200303448B (en) Pharmaceutical composition comprising condensed indole compound.
HK1056998B (en) Pharmaceutical composition comprising condensed indole compound
HK1109852A (en) Pharmaceutical composition comprising condensed indole compound
HK1109851A (en) Pharmaceutical composition comprising condensed indole compound
CN112057427A (zh) 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
JP2004505920A5 (enExample)
ZA200406065B (en) Pharmaceutical composition comprising N-((1-N-Buty-4-piperidinyl)methyl)-3,4-dihy-dro-2H-(1,3) oxazino (3,2-a) indole-10-carboxamide or salt and process thereof comprising dry granulation.
JP2025060441A (ja) ビラスチンを含有する製剤およびその製造方法
HK1190938A (en) Pharmaceutical solid preparation comprising benzazepines and production method thereof
HK1139324A (en) Pharmaceutical solid preparation comprising benzazepines and production method thereof
HK1072359B (en) Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process for preparing thereof comprising dry granulation

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS: ADD CO-INVENTORS; SHEPHERD, GILLIAN LOUISE; AMIN, NEETA BALKRISHAN;ILSON, BERNARD ENNO.

PC1 Assignment before grant (sect. 113)

Owner name: SMITHKLINE BEECHAM P.L.C.

Free format text: FORMER APPLICANT(S): SMITHKLINE BEECHAM P.L.C.; LABORATOIRE GLAXOSMITHKLINE S.A.S.

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: ADD CO-INVENTORS AMIN, NEETA BALKRISHAN; SHEPHERD, GILLIAN LOUISE; ILSON, BERNARD ENNO

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired